Koya In the News

Koya Medical Raises New Capital with OrbiMed to Support Growth

Today OrbiMed announced the closing of a financing for up to $30 million to support Koya's strategic expansion and continued growth.

Koya Medical Selected for Poster Presentation of the NILE Clinical Trial, awarded Gold medal at AMCP 2023

Koya Medical today announced their selection for a poster presentation of the NILE Trial at the upcoming AMCP conference.

Koya Medical Announces the Addition of Chief Medical Officer Dr. Thomas Maldonado to Their Executive Leadership Team

The addition of Dr. Maldonado further strengthens Koya Medical’s clinical advisory board, led by Stanley Rockson, M.D.

Koya Medical Presents Two Newly Published Clinical Studies for Dayspring Active Compression Treatments for Lymphedema and Venous Disease at the AVLS 2022 Annual Congress

Koya Medical presented two newly published clinical studies for the treatment of lymphedema and venous disease with its Dayspring active compression

Koya Medical Announces Two Clinical Data Publications for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease

Published Studies Reveal New Data About Edema Reduction,Patient Satisfaction and Quality of Life With Dayspring System

Man standing in his kitchen pouring some coffee with the Dayspring lower delivering treatment to his leg

Koya Medical Launches Dayspring Lower Extremity Active Compression Treatments for Lymphedema and Venous Disorders

Koya Medical Launches Dayspring Lower Extremity Active Compression Treatments and CMS Issues Three New Billing Codes

Man in a wheelchair outside wearing a Dayspring compression device on his leg and smiling

Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies for Lymphedema and Venous Disorders

Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Treatments for Lymphedema and Venous Disorders

Blue, red, and black confetti in the air

Reimagining Compression Therapy for Lymphedema and Venous Disease: A Podcast with Outcomes Rocket MedTech

Outcomes Rocket Podcast: Founder Discusses Treatment Gaps in Lymphedema and Koya Medical's Innovative Dayspring Treatment

Outcomes Rocket MedTech Podcast: Reimagining compression therapy for lymphedema and venous diseases

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

Interim data presented at American Vein and Lymphatic Society Annual Congress show reduction in limb volume, improved quality of life and adherence.

A middle-aged woman throwing a ball in her backyard while wearing a Dayspring compression device on her arm

Koya Medical and Essity Sponsor Forum for Physicians, Lymphedema Therapists and Researchers to Discuss Health

Space Forum Dinner discusses the implications of weightlessness in space travel on the lymphatic and venous systems and human adaptability

Astronaut in outer space working on a satellite wearing a spacesuit

Koya Medical Secures First Reimbursement Codes for Dayspring, for Lymphedema; Publishes Clinical Data Demonstrating Improved Function, Appearance, Mood and Symptoms

CMS issues new HCPCS codes for Dayspring, a novel wearable active compression treatment for lymphedema and venous diseases.

A female doctor helping a patient put on the Dayspring compression device on her arm

Koya Medical Receives FDA Clearance for Indication of First Mobility-Enabled Active Compression for Lower Extremities

Dayspring is now FDA cleared for lymphedema and venous disease treatment in both upper and lower extremities. Koya Medical also grows leadership team.

Three Koya Medical employees in front of a sign that says Koya's Mission, Transforming Venous and Lymphatic Care

Koya to Present at Oppenheimer MedTech, Tools & Diagnostics Summit

Join CEO and President Andy Doraiswamy, Ph.D., as he provides an overview of recent business milestones and developments with Dayspring™ on May 26th.

Andy Doraiswamy, PhD, Founder and President of Koya Medical

Ali Bauerlein Joins Koya Medical Board of Directors

Medical technology leader brings over 20 years of experience and a strong history of building shareholder value in the healthcare domain.

Ali Bauerlein, Board Director at Koya Medical

Koya Medical Closes $11MM Financing to Accelerate Treatment for Lymphedema and Venous Disorders

Koya Dayspring to provide lymphedema and venous insufficiency patients with greater freedom through their untethered wearable therapy device.

The Koya Medical team celebrates securing an A round with a toast

Sign up